
GE Healthcare
Investments
39Partners & Customers
10About GE Healthcare
GE Healthcare (NASDAQ: GEHC) is a medical technology company. It offers a range of medical products such as ultrasound systems, imaging systems, patient monitoring systems, and more. The company was founded in 1892 and is based in Chicago, Illinois.

Want to inform investors similar to GE Healthcare about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Expert Collections containing GE Healthcare
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find GE Healthcare in 2 Expert Collections, including Conference Exhibitors.
Conference Exhibitors
5,302 items
Digital Health
10,563 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Research containing GE Healthcare
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned GE Healthcare in 5 CB Insights research briefs, most recently on Aug 1, 2023.

Aug 1, 2023
The state of healthcare AI in 5 charts
Dec 17, 2020
5 Ways Digital Twins Could Improve HealthcareLatest GE Healthcare News
Sep 23, 2023
andresr/E+ via Getty Images When the US FDA granted full approval of Biogen (NASDAQ: BIIB ) and Eisai's ( OTCPK:ESAIY ) Alzheimer's treatment Leqembi (lecanemab), it was a boon to the two companies. It meant that the Centers for Medicare and Medicaid Services ( CMS ) would cover the drug. Patients also benefitted as Medicare would foot most of the bill for the cost of the drug, which has a list price of $16.5K. And due to requirements for taking the medicine, it also meant that other companies -- particularly in the diagnostics and imaging space -- could make money off of Leqembi uptake. While the full approval could help restore some of Biogen ( BIIB ) and Eisai's ( OTCPK:ESALF ) damaged reputation after its other approved Alzheimer's med, Aduhelm (aducanumab), failed to gain traction, getting people take the drug is, well, a process. A patient first has to have a confirmed diagnosis of mild cognitive impairment related to Alzheimer's or mild dementia. Those with more severe forms of the disease are not eligible for treatment. Next, a patient will have to get either a amyloid PET scan or spinal tap to confirm the presence of amyloid , a sticky protein in the brain believed to be associated with Alzheimer's. Here's the problem. Medicare only covers one of these PET scans per lifetime and only as part of a trial. Out-of-pocket costs for a PET scan can average $3K or more, according to the Alzheimer's Association . The imaging cost issue may go away soon if a proposal from CMS to eliminate the restriction on PET scans is eliminated. But even if it is, a Leqembi user will still need to have regular MRI scans due to the brain hemorrhaging and bleeding seen in some patients in clinical trials. While these hurdles might be a turnoff for some, it has the potential to benefit other companies in the process, such as those who provide diagnostics and imaging systems necessary for PET and MRI scans, and radiology centers where they will be conducted. Here's a look at some of the companies that could reap their own dividends courtesy of Leqembi. GE HealthCare Technologies (NASDAQ: GEHC ) is a healthcare equipment powerhouse, and one of its largest segments is diagnostic machines and supplies. The company's line of Omni Legend and Discovery CT/PET machines are already present in many radiology suites. Should demand for Leqembi take off, additional orders for these machines are almost certain to rise. GE Healthcare also provides chemistry solutions and cyclotrons to support tracer production that is used in the evaluation of scans. Siemens Healthineers ( OTCPK:SEMHF )( OTCPK:SMMNY ) is another diagnostics and imaging behemoth. Its Biograph family of CT/PET scanners is a direct competitor to GE HealthCare ( GEHC ). Because a spinal tap to collect cerebrospinal fluid can also be used to detect the presence of amyloid in the brain, Roche's ( OTCQX:RHHBY ) diagnostics segment markets a test that can detect the presence of amyloid from CSF. RadNet (NASDAQ: RDNT ) is one of the largest providers of diagnostic imaging services centers in the country with 357 centers in seven states. It is where a patient would get a amyloid pet scan or one of the regular MRI scans that Leqembi treatment requires. Diagnostic services providers Quest Diagnostics ( DGX ) and Laboratory Corporation of America ( LH ) could also see increased testing resulting from Leqembi. Labeling recommends that doctors test potential patients for the presence of the APOE4 gene, which is associated with a higher risk of brain hemorrhaging and bleeding seen with the drug.
GE Healthcare Investments
39 Investments
GE Healthcare has made 39 investments. Their latest investment was in MediView as part of their Series A on May 5, 2023.

GE Healthcare Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
5/16/2023 | Series A | MediView | $15M | Yes | 2 | |
8/16/2022 | Series F | AliveCor | Yes | 3 | ||
5/13/2022 | PIPE | Pulsenmore | $50M | Yes | 6 | |
6/28/2021 | Series D | |||||
12/3/2019 | Series B |
Date | 5/16/2023 | 8/16/2022 | 5/13/2022 | 6/28/2021 | 12/3/2019 |
---|---|---|---|---|---|
Round | Series A | Series F | PIPE | Series D | Series B |
Company | MediView | AliveCor | Pulsenmore | ||
Amount | $15M | $50M | |||
New? | Yes | Yes | Yes | ||
Co-Investors | |||||
Sources | 2 | 3 | 6 |
GE Healthcare Acquisitions
35 Acquisitions
GE Healthcare acquired 35 companies. Their latest acquisition was Caption Health on February 09, 2023.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
2/9/2023 | Grant | $75.33M | Acquired | 17 | ||
1/9/2023 | Private Equity | $3.53M | Acquired | 24 | ||
11/20/2020 | Grant | Acquired | 3 | |||
11/28/2017 | Grant | |||||
7/10/2017 |
Date | 2/9/2023 | 1/9/2023 | 11/20/2020 | 11/28/2017 | 7/10/2017 |
---|---|---|---|---|---|
Investment Stage | Grant | Private Equity | Grant | Grant | |
Companies | |||||
Valuation | |||||
Total Funding | $75.33M | $3.53M | |||
Note | Acquired | Acquired | Acquired | ||
Sources | 17 | 24 | 3 |
GE Healthcare Partners & Customers
10 Partners and customers
GE Healthcare has 10 strategic partners and customers. GE Healthcare recently partnered with Mayo Clinic on September 9, 2023.
Date | Type | Business Partner | Country | News Snippet | Sources |
---|---|---|---|---|---|
9/14/2023 | Partner | United States | Mayo Clinic, GE HealthCare Ink Medical Imaging & Theranostics Deal Mayo Clinic and GE HealthCare began a strategic healthcare partnership for R&D programs that plan to transform patient and clinician experience in radiology practice and novel therapy delivery . | 8 | |
9/6/2023 | Partner | United States | The first innovative AI application from the collaboration is the schedule predictions dashboard of Radiology , a digital imaging tool that helps optimize scheduling , reduce cost , and free providers from administrative burden , allowing more time for the clinician-patient relationship , according to a statement issued today by GE HealthCare , which added that Radiology is commercially available to healthcare institutions . | 1 | |
9/6/2023 | Partner | United States | GE HealthCare has partnered with Mass General Brigham to co-develop a new artificial intelligence algorithm for improving imaging throughput , the two announced Wednesday . | 3 | |
9/1/2023 | Vendor | ||||
8/22/2023 | Vendor |
Date | 9/14/2023 | 9/6/2023 | 9/6/2023 | 9/1/2023 | 8/22/2023 |
---|---|---|---|---|---|
Type | Partner | Partner | Partner | Vendor | Vendor |
Business Partner | |||||
Country | United States | United States | United States | ||
News Snippet | Mayo Clinic, GE HealthCare Ink Medical Imaging & Theranostics Deal Mayo Clinic and GE HealthCare began a strategic healthcare partnership for R&D programs that plan to transform patient and clinician experience in radiology practice and novel therapy delivery . | The first innovative AI application from the collaboration is the schedule predictions dashboard of Radiology , a digital imaging tool that helps optimize scheduling , reduce cost , and free providers from administrative burden , allowing more time for the clinician-patient relationship , according to a statement issued today by GE HealthCare , which added that Radiology is commercially available to healthcare institutions . | GE HealthCare has partnered with Mass General Brigham to co-develop a new artificial intelligence algorithm for improving imaging throughput , the two announced Wednesday . | ||
Sources | 8 | 1 | 3 |
GE Healthcare Team
163 Team Members
GE Healthcare has 163 team members, including current Founder, Chief Executive Officer, Peter J Arduini.
Name | Work History | Title | Status |
---|---|---|---|
Peter J Arduini | Founder, Chief Executive Officer | Current | |
Name | Peter J Arduini | ||||
---|---|---|---|---|---|
Work History | |||||
Title | Founder, Chief Executive Officer | ||||
Status | Current |
Compare GE Healthcare to Competitors

Carestream is a provider of medical imaging systems, x-ray imaging systems for non-destructive testing, and precision contract coating services for a wide range of industrial, medical, electronic, and other applications. It was founded in 2007 and is based in Rochester, New York.
ADEX develops a control technology brought to life through a self-tuning Artificial Intelligence platform. The technology boosts performance and increases economic outcomes, safety, and reliability within industrial applications.

Us2.ai operates as an online healthcare technology platform. It provides automated echo reports with disease detection. It uses a heart risk detection tool to improve patient outcomes and expand healthcare access. It was formerly known as eko.ai. The company was founded in 2017 and is based in Singapore.

Ultromics provides autonomous echocardiography analysis through artificial intelligence (AI) solutions, empowering physicians to make decisions when diagnosing cardiovascular disease. Its cloud-based service, EchoGo, uses artificial intelligence to fully automate the pathway to diagnosis, providing reports for clinicians without any need for physical software on-site. The company was founded in 2017 and is based in Oxford, United Kingdom.
Enlite Research provides wireless and bluetooth enabled building management solutions.
Medis Medical Imaging Systems provides software solutions that enable clinicians, technicians and researchers to accurately quantify medical images.